SEARCH

SEARCH BY CITATION

Abstract

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

In adult animals, leptin is an adipose-derived hormone that is important primarily in the regulation of energy balance during short- and long-term changes in nutritional state. Expression of leptin and its receptors is widespread in fetal and placental tissues, although the role of leptin as a nutritional signal in utero is unclear. Before birth, leptin concentration correlates with several indices of fetal growth, and may be an endocrine marker of fetal size and energy stores in the control of metabolism and maturation of fetal tissues. In addition, leptin synthesis and plasma concentration can be modified by insulin, glucocorticoids, thyroid hormones and oxygen availability in utero, and therefore, leptin may be part of the hormonal response to changes in the intrauterine environment. Evidence is emerging to show that leptin has actions before birth that are tissue-specific and may occur in critical periods of development. Some of these actions are involved in the growth and development of the fetus and others have long-term consequences for the control of energy balance in adult life.

In adult animals, the role of leptin in the control of energy balance and a range of other physiological systems has become increasingly well characterised (Harris, 2000; Margetic et al. 2002). Leptin is primarily synthesised by white adipose tissue and acts as an endocrine signal of energy reserves to the hypothalamus and other tissues in the coordination of appetite and metabolism with nutrient availability (Ahima & Flier, 2000). In adult life, leptin has a variety of actions in the control of energy balance, both in the long-term regulation of body weight and in the short-term regulation of metabolic and other endocrine responses to fasting (Ahima & Flier, 2000; Harris, 2000). It has also been shown to be involved in the activity of the immune system, and the onset and maintenance of reproductive function (Caprio et al. 2001; Lago et al. 2008). Before birth, however, the role of leptin as a nutritional signal, and the concept of ‘appetite’ in the intrauterine environment, is less clear when the fetus normally receives a continuous transplacental supply of glucose and other nutrients for growth and metabolism. This review will focus on the expression, and regulation, of leptin in utero, and the contribution of leptin to the hormonal control of fetal growth and development, with particular emphasis on the sheep fetus as an experimental animal model.

Expression of leptin in fetal and placental tissues

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

Leptin has been measured in the fetal circulation of different animal species, including human beings and sheep, from mid-gestation (Matsuda et al. 1999; Chen et al. 2000; Ogeuh et al. 2000; Ehrhardt et al. 2002). In the ovine fetus, plasma leptin concentration and adipose leptin mRNA abundance increase towards term which suggests that fetal adipose tissue is a major source of circulating leptin in utero (Yuen et al. 1999; Forhead et al. 2002). However, plasma leptin may also originate from a range of other fetal and placental tissues. In all species studied to date, leptin and leptin receptor gene expression have been found to be widespread in fetal and placental tissues (Table 1). Leptin may, therefore, have local as well as endocrine actions in the fetus which may be important for normal growth and development before birth.

Table 1.  Expression of leptin and leptin receptors in fetal and placental tissues in different animal species
SpeciesLeptinLeptin receptorReferences
ProteinmRNAProteinmRNA
HumanPlacentaPlacentaPlacentaPlacentaHassink et al. 1997
 Adipose tissueAdipose tissueOesophagusAdipose tissueHoggard et al. 1997
 StomachStomachStomachAnterior pituitaryShimon et al. 1998
   Small and large intestineStomachLea et al. 2000
    Small intestineLepercq et al. 2001
     Aparicio et al. 2005
Baboon Placenta LungHenson et al. 1999, 2004
  Lung   
SheepPlacentaPlacentaPlacentaPlacentaHoggard et al. 1997
 Adipose tissueAdipose tissueAdipose tissueAdipose tissueYuen et al. 1999
  BrainLiverHeartBuchbinder et al. 2001
  HeartSkeletal muscleLiverThomas et al. 2001
  Liver KidneyEhrhardt et al. 2002
  Kidney Skeletal muscleO'Connor et al. 2007
  Skeletal muscle  Forhead et al. 2008
PigPlacentaAdipose tissuePlacentaAdipose tissueAshworth et al. 2000
    Umbilical cordChen et al. 2000
    BrainLin et al. 2000
    Intestines 
    Heart 
    Liver 
    Muscle 
MousePlacentaPlacentaPlacentaPlacentaHoggard et al. 1997
 Cartilage and boneCartilage and boneCartilage and boneCartilage and boneHoggard et al. 2000
 HeartHeartHair folliclesHair follicles 
 LiverLiverBrainBrain 
 Hair folliclesHair folliclesLungLung 
   KidneyKidney 
    Testis 
RatPlacenta PlacentaPlacentaHoggard et al. 1997
   BrainPancreatic isletsMatsuda et al. 1999
     Islam et al. 2000
     Smith and Waddell, 2002

The extent to which leptin is transported, and synthesised and secreted, by the placenta, and the contribution that maternal and placental leptin make to circulating levels in the fetus, appears to vary between animal species and with the stage of gestation studied. In human and non-human primate pregnancy, the placenta expresses significant amounts of leptin mRNA (Henson et al. 1999; Lea et al. 2000), although studies in vitro using the dually perfused human placenta at term show that 98% of placental leptin is secreted into the maternal circulation (Linnemann et al. 2000). Furthermore, leptin transfer across human choriocarcinoma BeWo cells occurs at a relatively low rate (Wyrwoll et al. 2005), and no relationship exists between plasma leptin concentration in maternal and umbilical blood at delivery (Schubring et al. 1997). In rodent and ovine species, leptin mRNA is detected in the placenta albeit at relatively low levels (Hoggard et al. 1997; Ashworth et al. 2000; Thomas et al. 2001; O'Connor et al. 2007). In contrast to human pregnancy, a positive correlation has been observed between plasma leptin concentrations in the ewe and fetus in well-fed and undernourished conditions during late gestation (Yuen et al. 2002). Further studies are required, however, to establish whether this relationship is due to placental transfer of leptin from the maternal to fetal circulation, or whether maternal body composition has other, indirect, effects on the secretory capacity of adipose tissue in the fetus. The rat placenta appears to be permeable to leptin, as significant transfer of radiolabelled leptin to the fetus has been demonstrated after injection into the mother (Smith & Waddell, 2003). In some species, therefore, leptin in the fetal circulation may have originated from the mother and/or the placenta.

Leptin as a signal in response to the intrauterine environment

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

Leptin expression in the fetus is altered by different intrauterine conditions, and these responses vary according to the nature of the stressor. Table 2 summarises the effects of a variety of experimental manipulations on plasma leptin concentration and adipose leptin gene expression in the ovine fetus. Moderate changes in maternal nutrition do not appear to affect tissue leptin expression or circulating leptin in fetal sheep. While maternal undernutrition influences plasma leptin in the pregnant ewe, there is little change in plasma leptin or adipose leptin mRNA abundance in the fetus (Yuen et al. 2002; Ehrhardt et al. 2002; Edwards et al. 2005). Maternal overnutrition increases leptin gene expression in fetal adipose tissue, without affecting plasma leptin concentration (Muhlhausler et al. 2002, 2007). In this study, adipose leptin mRNA abundance was positively correlated with plasma insulin concentration in utero (Muhlhausler et al. 2007). Indeed, leptin gene expression in adipose tissue is clearly regulated by circulating insulin in the fetus as in the adult animal. In fetal sheep, chronic hyperglycaemia and hyperinsulinaemia causes an increase in adipose leptin mRNA, while hypoglycaemia and hypoinsulinaemia leads to a reduction in adipose leptin mRNA levels (Devaskar et al. 2002). Similarly, in acute studies, hyperinsulinaemia with euglycaemia causes a two-fold increase in leptin gene expression in fetal adipose tissue, whereas hyperglycaemia with euinsulinaemia has no effect on adipose leptin mRNA abundance (Devaskar et al. 2002).

Table 2.  Effect of manipulation of the intrauterine environment on leptin expression in the ovine fetus
Intrauterine manipulationEffect on leptin expressionReference
Maternal undernutrition (70% for 139 days)No change in plasma leptinEdwards et al. 2005
Maternal undernutrition (55% for 13 days)No change in plasma leptinEhrhardt et al. 2002
Maternal undernutrition (50% for 30 days)No change in adipose leptin mRNAYuen et al. 2002
Maternal overnutrition (155% for 25 days)[UPWARDS ARROW] adipose leptin mRNA and no change in plasma leptinMühlhäusler et al. 2002, 2007
Chronic fetal hypoglycaemia and hypoinsulinaemia (36–76 days)[DOWNWARDS ARROW] adipose leptin mRNADevaskar et al. 2002
Chronic fetal hyperglycaemia and hyperinsulinaemia (14–20 days)[UPWARDS ARROW] adipose leptin mRNA 
Acute fetal hyperinsulinaemia and euglycaemia (24 h)[UPWARDS ARROW] adipose leptin mRNA 
Acute fetal hyperglycaemia and euinsulinaemia (24 h)No change in adipose leptin mRNA 
Chronic 50% reduction in uterine blood flow (23 days)[UPWARDS ARROW] plasma leptinBuchbinder et al. 2001
Placental carunclectomy[DOWNWARDS ARROW] adipose leptin mRNA and no change in plasma leptinDuffield et al. 2008
Chronic hypoxia at high altitude (100 days)[UPWARDS ARROW] plasma leptin and [UPWARDS ARROW] adipose and placental leptin mRNADucsay et al. 2006
Fetal cortisol infusion (5 days)[UPWARDS ARROW] plasma leptin and [UPWARDS ARROW] adipose leptin mRNAForhead et al. 2002
  O'Connor et al. 2007
Maternal dexamethasone treatment (2 doses at 24 h intervals)[UPWARDS ARROW] plasma leptin and [UPWARDS ARROW] adipose leptin mRNAO'Connor et al. 2007
Fetal hypothyroidism by thyroidectomy[UPWARDS ARROW] plasma leptin and [UPWARDS ARROW] adipose leptin mRNAO'Connor et al. 2007

Placental insufficiency induced in sheep by carun-clectomy causes a decrease in leptin mRNA expression in perirenal adipose tissue of the fetus with no change in circulating leptin concentration (Duffield et al. 2008). Suppression of leptin gene expression in this model of intrauterine undernutrition and growth retardation may be due to low plasma concentrations of insulin and glucose in utero (Duffield et al. 2008). In contrast, chronic undernutrition of the ovine fetus by occlusion of the uterine artery and a reduction in uterine blood flow leads to a rise in plasma leptin concentration (Buchbinder et al. 2001). Likewise, elevated plasma leptin, when expressed on a weight-specific basis, has been reported in growth-retarded human fetuses with lactacidaemia and abnormal Doppler imaging of the umbilical cord (Cetin et al. 2000). Stimulation of plasma leptin during fetal distress may be related to changes in oxygen availability and/or adrenocortical activity since plasma leptin in sheep fetuses has been shown to correlate inversely with the arterial partial pressure of oxygen and positively with plasma cortisol concentration (Forhead et al. 2002). Long-term hypoxia induced in sheep at high altitude for most of gestation increases plasma leptin in the fetus, and gene expression of leptin in placenta and fetal adipose tissue, without any change in plasma glucose or insulin concentrations (Ducsay et al. 2006). Glucocorticoids modify leptin expression before and after birth: in fetal sheep, leptin mRNA abundance in adipose tissue, and circulating leptin concentration, are increased by cortisol and dexamethasone treatment, and suppressed by fetal adrenalectomy (O'Connor et al. 2007). Interestingly, however, maternal dexamethasone administration in pregnant rats decreases leptin concentration in the fetal circulation in association with changes in placental leptin receptor expression and reductions in placental content and transfer of leptin (Sudgen et al. 2001; Smith & Waddell, 2002, 2003). Thyroid hormones also affect circulating and adipose levels of leptin before birth. Hypothyroidism in the ovine fetus near term, induced by thyroidectomy, increases plasma leptin and leptin mRNA abundance in fetal adipose tissue (O'Connor et al. 2007). Moreover, leptin synthesis by fetal adipose tissue shows negative feedback control to regulate circulating concentrations. Intravenous infusion of recombinant ovine leptin in fetal sheep reduces leptin mRNA abundance in perirenal adipose tissue (Yuen et al. 2003). It is also apparent that circulating leptin concentration in utero may depend upon the breed, and genetic background, of the sheep used in experimental studies. The Welsh Mountain fetus has lower plasma leptin concentration to the Merino fetus, and the developmental increase in adipose leptin mRNA abundance seen in both breeds near term is accompanied by a rise in plasma leptin in the fetuses of the Welsh Mountain, but not Merino breed (Yuen et al. 1999, 2004; Forhead et al. 2002; O'Connor et al. 2007). These differences may reflect the amount, and secretory capacity, of adipose tissue in the fetuses of different sheep breeds and the physiological consequences of breeding sheep for different environmental conditions. Therefore, leptin synthesis and circulating concentration in utero respond to a range of nutrient, hormonal and genetic influences, although little is known about how these factors affect the expression of leptin receptors in fetal tissues. Leptin may be one of a number of hormones, including insulin, glucocorticoids and thyroid hormones, that signal changes in the intrauterine environment and, in turn, govern appropriate responses in growth and development in fetal tissues.

Leptin and growth of the fetus

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

The widespread localisation of leptin receptors in the developing fetus, especially in bone and cartilage, has led to the proposal that leptin is involved in the control of fetal growth. In human infants at term, umbilical leptin concentration has been correlated with placental weight and with a number of indices of fetal growth including body weight and length, head circumference, ponderal index, adiposity and bone mineral content and density (Hassink et al. 1997; Varvarigou et al. 1999; Javaid et al. 2005; Valuniene et al. 2007). Low concentrations of circulating and placental leptin have been reported in babies that are small for their gestational age while high concentrations occur in the macrosomic offspring of diabetic mothers (Lea et al. 2000). Similarly, in sheep fetuses, adipose leptin mRNA abundance correlates with fetal bodyweight at mid and late gestation (Yuen et al. 1999). However, in human infants at delivery, positive relationships have also been identified between umbilical leptin and other hormones known to be associated with nutritional status and intrauterine growth, such as insulin and insulin-like growth factor-I (Maffeis et al. 1999). It is difficult, therefore, to determine the extent to which circulating leptin in utero is an important physiological regulator of fetal growth or simply reflects adipose and placental tissue mass, and/or the prevailing insulin concentration in the fetal circulation.

Clinical and experimental studies of leptin gene mutations have provided no evidence to support leptin as a major growth factor in fetal life. Human and murine neonates with genetic leptin deficiency are reported to be of normal morphology and birth weight (Montague et al. 1997; Mounzih et al. 1998). In ob/ob mice with a mutation in the leptin gene, the establishment of pregnancy is leptin dependent, but withdrawal of leptin replacement from 0.5 days of gestation has no effect on litter size or fetal weights (Mounzih et al. 1998). Furthermore, in fetal sheep during late gestation, intravenous administration of recombinant ovine leptin for 4–5 days does not influence body or organ weights, or the rate of linear spinal growth (Yuen et al. 2003; Forhead et al. 2008). Many of these studies have measured growth in terms of body weight and gross morphology, and more detailed analyses at the tissue and cellular level are required to determine fully the importance of leptin as a growth factor in fetal life. Studies in vitro have demonstrated that leptin stimulates proliferation of pancreatic islet cells from fetal rats (Islam et al. 2000). Furthermore, leptin is important for the normal development and migration of neuronal and glial lineage cells in the cerebral cortex of fetal mice (Udagawa et al. 2007). In perirenal adipose tissue of fetal sheep, leptin infusion upregulates insulin-like growth factor-I receptor expression and causes a shift in the relative proportions of unilocular and multilocular cells (Yuen et al. 2003; Forhead et al. 2008). The effects of leptin on growth and development in the fetus, therefore, may be cell- and tissue-specific rather than on general body growth and size. While the evidence for leptin as a growth-promoting factor before birth remains inconclusive, the relationship between circulating leptin and fetal size, and specifically adipose mass, suggests that leptin signals energy reserves in utero as it does in adult life.

Leptin derived from the placenta may have an important role in the control of placental growth and function, and consequently, the growth of the fetus. Placental leptin concentration is elevated in pregnant mice heterozygous for a mutation in the leptin receptor, and this is associated with an increase in fetal weight near term, both in mutant and wild-type pups (Yamashita et al. 2001). Furthermore, administration of leptin to wild-type pregnant mice decreases placental leptin content and leads to reductions in placental and fetal weights (Yamashita et al. 2001). In human trophoblast cells in vitro, exogenous leptin treatment has mitogenic and anti-apoptotic effects, while inhibition of endo-genous placental leptin expression, using an anti-sense oligonucleotide, reduces cell proliferation and increases apoptotic cell number and caspase-3 activity (Margarinos et al. 2007). Studies in vitro have also shown that leptin upregulates nitric oxide production and lipolysis in the human and rodent placenta at term (White et al. 2004, 2006) with possible consequences for placental blood flow and transfer of free fatty acids to the fetus. Furthermore, leptin stimulates activity of the amino acid transporter system A in human placental villous fragments at term (Jansson et al. 2003). This sodium-dependent transporter is responsible for the placental transfer of neutral amino acids to the fetus, and, coincident with placental leptin content (Lea et al. 2000), is known to be down-regulated in intrauterine growth retardation and upregulated in diabetic pregnancies (Jansson et al. 2003).

Leptin and energy balance of the fetus

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

In adult animals, leptin is a key regulator of feeding behaviour via actions on hypothalamic neural pathways (Trayhurn & Bing, 2006). Before birth, the neuropeptides involved in these pathways are present in the developing hypothalamus (Muhlhausler et al. 2004; Beloosesky et al. 2006), but the control and physiological importance of appetite-regulatory neural networks in the fetus are unclear. In rodents, milk intake over the immediate newborn period is relatively insensitive to leptin, primarily due to immaturity in the neural connections of the arcuate nucleus (Mistry et al. 1999; Bouret & Simerly, 2006). Indeed, it may be crucial that feeding behaviour in the newborn is resistant to the satiating effects of leptin at a time when levels are relatively high, and when leptin may have alternative actions in the maturation of tissues and physiological systems important for neonatal survival. Leptin does appear, however, to be involved in establishing the neural networks that regulate feeding behaviour in postnatal life (McMillen et al. 2005, Bouret & Simerly, 2006). In rodents, these hypothalamic pathways are established in the first 2 weeks of life, and are dependent on the postnatal surge in plasma leptin over this period (Bouret et al. 2004). Leptin-deficient ob/ob mice show abnormal development of neural projections from the arcuate nucleus, which can be corrected by leptin treatment in neonatal but not adult life (Bouret et al. 2004). Furthermore, in rats born to mothers undernourished during pregnancy, leptin administration in the neonatal period has been shown to prevent the programmed development of obesity in later life (Vickers et al. 2005, 2008). Since the rodent brain develops later than the human and ovine brain, leptin-sensitive formation of the hypothalamic appetite-regulatory network may occur before birth in more precocial species (McMillen et al. 2005, Bouret & Simerly, 2006). Exposure of the fetus to leptin at critical periods of development may, therefore, have important programming consequences for the formation and activity of hypothalamic networks responsible for appetite regulation and energy balance in adult life (McMillen et al. 2005, Bouret & Simerly, 2006).

Relatively few studies have investigated the effect of leptin on metabolism and energy balance in the fetus. In fetal sheep during late gestation, intravenous administration of leptin reduces glycogen content and the activities of the gluconeogenic enzymes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, in the liver without influencing plasma insulin or hepatic insulin signalling molecules (Forhead et al. 2008). Furthermore, intracerebroventricular leptin administration has no effect on plasma glucose or insulin concentrations, or on glucose clearance or insulin responsiveness to a glucose challenge (Howe et al. 2002). Therefore, in normal conditions, leptin may be responsible, in part, for suppression of endogenous glucose production in utero when adipose energy stores are increasing towards term and transplacental nutrient delivery is sufficient to meet the energy requirements of the fetus. In macrosomic babies of diabetic mothers, however, hyperleptinaemia may contribute to neonatal hypoglycaemia by impairing glycogenolytic and gluconeogenic capacities at birth.

Leptin and maturation of the fetus near term

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

Towards term, a number of structural and functional changes occur in fetal tissues in preparation for the transition from intrauterine to extrauterine and independent life. Many of these changes are triggered by the rise in glucocorticoid concentration that occurs in the fetal circulation near term (Fowden et al. 1998). In fetal sheep, both endogenous and synthetic glucocorticoids cause an increase in adipose leptin mRNA and circulating leptin concentration (Forhead et al. 2002; O'Connor et al. 2007), which has led to the suggestion that some of the maturational effects of glucocorticoids may be mediated by leptin. One example is the developmental and glucocorticoid-dependent onset of surfactant production in fetal lungs near term. Expression of leptin and leptin receptors has been demonstrated in fetal lungs of rodent and primate species (Hoggard et al. 1997; Henson et al. 2004), and, in baboon fetuses, pulmonary leptin receptor mRNA abundance increases between mid and late gestation (Henson et al. 2004). In addition, both dexamethasone and pulmonary stretch have been shown to stimulate leptin expression by fetal rat lung fibroblasts in cell culture (Torday et al. 2002; Torday & Rehan, 2002). In vitro studies using fetal tissue suggest that leptin may be an important regulator of pulmonary surfactant synthesis before birth. Leptin increases surfactant protein mRNA and protein levels in lung explants from fetal rats (Kirwin et al. 2006), and promotes surfactant phospholipid synthesis in type II pneumocytes isolated from fetal rats and rabbits (Bergen et al. 2002; Torday et al. 2002). Furthermore, stretch-induced production of surfactant phospholipids by fetal rat type II pneumocytes in vitro is abolished by leptin antagonism using a leptin antibody (Torday & Rehan, 2002). The role of leptin in pulmonary maturation has not been investigated in detail in the whole animal, although relative lung weights and immunostaining for surfactant proteins B and C are increased in rat fetuses whose mothers were treated with leptin during late gestation (Kirwin et al. 2006). Taken together, these observations suggest that leptin may act as a paracrine and/or endocrine regulator of surfactant production in the fetal lungs near term, although further studies are required to confirm the importance of leptin in vivo.

While glucocorticoids promote synthesis and secretion of leptin in the ovine fetus, in turn, leptin appears to regulate the activity of the fetal hypothalamic–pituitary–adrenal axis near term. In sheep fetuses during late gestation, intravascular or intracerebroventricular infusions of leptin suppress the normal prepartum increase in pulsatile adrenocorticotrophic hormone and cortisol secretion, without any change in pituitary sensitivity to exogenous arginine vasopressin or corticotrophin-releasing hormone (Howe et al. 2002; Yuen et al. 2004). Although no change in gestational length has been observed in leptin-treated animals (Yuen et al. 2004), the existence of a negative feedback loop between leptin and the hypothalamic–pituitary–adrenal axis in the ovine fetus may have implications for the onset of parturition, known to depend on fetal glucocorticoids in this species.

Conclusions

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

Circulating leptin in utero is an endocrine signal of both fetal and placental size, and may indicate the nutritional status and energy reserves of the fetus to the mother, the placenta and to a range of fetal tissues. Although the role of leptin as a growth factor before birth remains inconclusive, the widespread expression of leptin in fetal and placental tissues, and the increasing evidence of tissue-specific actions, suggest that leptin has physiological significance in fetal life. Leptin concentration in the fetus responds to a range of nutritional and endocrine stimuli, and therefore, it may signal changing nutrient availability, particularly in the control of glucogenesis and tissue maturation during late gestation and the establishment of neural pathways important for energy balance in later life.

References

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix
  • Ahima RS & Flier JS (2000). Leptin. Annu Rev Physiol 62, 413437.
  • Aparicio T, Kermorgant S, Darmoul D, Guilmeau S, Hormi K, Mahieu-Caputo D & Lehy T (2005). Leptin and Ob-Rb receptor isoform in the human digestive tract during fetal development. J Clin Endocrinol Metab 90, 61776184.
  • Ashworth CJ, Hoggard N, Thomas L, Mercer JG, Wallace JM & Lea RG (2000). Placental leptin. Rev Reprod 5, 1824.
  • Beloosesky R, Gayle DA, Amidi F, Ahanya SN, Desai M & Ross MG (2006). Ontogenic expression of putative feeding peptides in the rat fetal brain and placenta. Nutr Neurosci 9, 3340.
  • Bergen HT, Cherlet TC, Manuel P & Scott JE (2002). Identification of leptin receptors in lung and isolated fetal type II cells. Am J Respir Cell Mol Biol 27, 7177.
  • Bouret SG, Draper SJ & Simerly RB (2004). Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108110.
  • Bouret SG & Simerly RB (2006). Developmental programming of hypothalamic feeding circuits. Clin Genet 70, 295301.
  • Buchbinder A, Lang U, Baker RS, Khoury JC, Mershon J & Clark KE (2001). Leptin in the ovine fetus correlated with fetal and placental size. Am J Obstet Gynecol 185, 786791.
  • Caprio M, Fabbrini E, Isidori AM, Aversa A & Fabbri A (2001). Leptin in reproduction. Trends Endocrinol Metab 12, 6572.
  • Cetin I, Morpurgo PS, Radaelli T, Taricco E, Cortelazzi D, Bellotti M, Pardi G & Beck-Peccoz P (2000). Fetal plasma leptin concentrations: relationships with different intrauterine growth patterns from 19 weeks to term. Pediatr Res 48, 646651.
  • Chen X, Lin J, Hausman DB, Martin RJ, Dean RG & Hausman GJ (2000). Alterations in fetal adipose tissue leptin expression correlate with the development of adipose tissue. Biol Neonate 78, 4147.
  • Devaskar SU, Anthony R & Hay W (2002). Ontogeny and insulin regulation of fetal ovine white adipose tissue leptin expression. Am J Physiol Regul Integr Comp Physiol 282, R341R348.
  • Ducsay CA, Hyatt K, Mlynarczyk M, Kaushal KM & Myers DA (2006). Long-term hypoxia increases leptin receptors and plasma leptin concentrations in the late-gestation ovine fetus. Am J Physiol Regul Integr Comp Physiol 291, R1406R1413.
  • Duffield JA, Vuocolo T, Tellam RL, Yuen BS, Muhlhausler BS & McMillen IC (2008). Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep. Am J Physiol Regul Integr Comp Physiol 294, R1413R1419.
  • Edwards LJ, McFarlane JR, Kauter KG & McMillen IC (2005). Impact of periconceptual nutrition on maternal and fetal leptin adiposity in singleton and twin pregnancies. Am J Physiol Regul Integr Comp Physiol 288, R39R45.
  • Ehrhardt RA, Bell AW & Boisclair YR (2002). Spatial and developmental regulation of leptin in fetal sheep. Am J Physiol Regul Integr Comp Physiol 282, R1628R1635.
  • Forhead AJ, Lamb CA, Franko KL, O'Connor DM, Wooding FBP, Cripps RL, Ozanne S, Blache D, Shen QW, Du M & Fowden AL (2008). Role of leptin in the regulation of growth and carbohydrate metabolism in the ovine fetus during late gestation. J Physiol 586, 23932403.
  • Forhead AJ, Thomas L, Crabtree J, Hoggard N, Gardner D, Giussani DA & Fowden AL (2002). Plasma leptin concentration in fetal sheep during late gestation: ontogeny and effect of glucocorticoids. Endocrinology 143, 11661173.
  • Fowden AL, Li J & Forhead AJ (1998). Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc 57, 113122.
  • Harris RBS (2000). Leptin-much more than a satiety signal. Ann Rev Nutr 20, 4575.
  • Hassink SG, De Lancey E, Sheslow DV, Smith-Kirwin SM, O'Connor DM, Considine RV, Opentanova I, Dostal K, Spear ML, Leef K, Ash M, Spitzer AR & Funanage VL (1997). Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics 100, E1.
  • Henson MC, Castracane VD, O'Neil JS, Gimpel T, Swan KF, Green AE & Shi W (1999). Serum leptin concentrations and expression of leptin transcripts in placental trophoblast with advancing baboon pregnancy. J Clin Endocrinol Metab 84, 25432549.
  • Henson MC, Swan KF, Edwards DE, Hoyle GW, Purcell J & Castracane VD (2004). Leptin receptor expression in fetal lung increases in late gestation in the baboon: a model for human pregnancy. Reproduction 127, 8794.
  • Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P & Mercer JG (1997). Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci U S A 94, 1107311078.
  • Hoggard N, Hunter L, Lea RG, Trayhurn P & Mercer JG (2000). Ontogeny of the expression of leptin and its receptor in the murine fetus and placenta. Brit J Nutr 83, 317326.
  • Howe DC, Gertler A & Challis JRG (2002). The late gestation increase in circulating ACTH and cortisol in the fetal sheep is suppressed by intracerebroventricular infusion of recombinant ovine leptin. J Endocrinol 174, 259266.
  • Islam MS, Sjoholm A & Emilsson V (2000). Fetal pancreatic islets express functional leptin receptors and leptin stimulates proliferation of fetal islet cells. Int J Obes Relat Metab Disord 24, 12461253.
  • Jansson N, Greenwood SL, Johansson BR, Powell TL & Jansson T (2003). Leptin stimulates the activity of the System A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab 88, 12051211.
  • Javaid MK, Godfrey KM, Taylor P, Robinson SM, Crozier SR, Dennison EM, Robinson JS, Breier BR, Arden NK & Cooper C (2005). Umbilical cord leptin predicts bone mass. Calcif Tissue Int 76, 341347.
  • Kirwin SM, Bhandari V, Dimatteo D, Barone C, Johnson L, Paul S, Spitzer AR, Chander A, Hassink SG & Funanage VL (2006). Leptin enhances lung maturity in the fetal rat. Pediatr Res 60, 200204.
  • Lago R, Gomez R, Lago F, Gomez-Reino J & Gualillo O (2008). Leptin beyond body weight regulation – current concepts concerning its role in immune function and inflammation. Cell Immunol 252, 139145.
  • Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L & Hoggard N (2000). Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Human Reprod 6, 763769.
  • Lepercq J, Challier J-C, Guerre-Millo M, Cauzac M, Vidal H & Hauguel-de Mouzon S (2001). Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 86, 24092413.
  • Lin J, Barb CR, Matteri RL, Kraeling RR, Chen X, Meinersmann RJ & Rampacek GB (2000). Long form leptin receptor mRNA expression in the brain, pituitary, and other tissues in the pig. Domest Anim Endocrinol 19, 5361.
  • Linnemann K, Malek A, Sager R, Blum WF, Schneider H & Fusch C (2000). Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 85, 42984301.
  • McMillen IC, Adam CL & Muhlhausler BS (2005). Early origins of obesity: programming the appetite regulatory system. J Physiol 565, 917.
  • Maffeis C, Moghetti P, Vettor R, Lombardi AM, Vecchini S & Tato L (1999). Leptin concentration in newborns' cord blood: relationship to gender and growth-regulating hormones. Int J Obes Relat Metab Disord 23, 943947.
  • Magarinos MP, Sanchez-Margalet V, Kotler M, Calvo JC & Varone CL (2007). Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 76, 203210.
  • Margetic S, Gazzola C, Pegg GG & Hill RA (2002). Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26, 14071433.
  • Matsuda J, Yokota I, Iida M, Murakami T, Yamada M, Saijo T, Naito E, Ito M, Shima K & Kuroda Y (1999). Dynamic changes in serum leptin concentrations during the fetal and neonatal periods. Pediatr Res 45, 7175.
  • Mistry AM, Swick A & Romsos DR (1999). Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice. Am J Physiol Regul Integr Comp Physiol 277, R742R747.
  • Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB & O'Rahilly S (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903908.
  • Mounzih K, Qui J, Ewart-Toland A & Chehab FF (1998). Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state. Endocrinology 139, 52595262.
  • Muhlhausler BS, Duffield JA & McMillen IC (2007). Increased maternal nutrition stimulates perioxisome proliferators activated receptor-γ, adiponectin, and leptin messenger ribonucleic acid expression in adipose tissue before birth. Endocrinology 148, 878885.
  • Muhlhausler BS, McMillen IC, Rouzaud G, Findlay PA, Marrocco EM, Rhind SM & Adam CL (2004). Appetite regulatory neuropeptides are expressed in the sheep hypothalamus before birth. J Neuroendocrinol 16, 502507.
  • Muhlhausler BS, Roberts CT, McFarlane JR, Kauer KG & McMillen IC (2002). Fetal leptin is a signal of fat mass independent of maternal nutrition in ewes fed at or above maintenance energy requirements. Biol Reprod 67, 493499.
  • O'Connor DM, Blache D, Hoggard N, Brookes E, Wooding FBP, Fowden AL & Forhead AJ (2007). Developmental control of plasma leptin and adipose leptin mRNA in the ovine fetus during late gestation: role of glucocorticoids and thyroid hormones. Endocrinology 148, 37503757.
  • Ogeuh O, Sooranna S, Nicolaides KH & Johnson MR (2000). The relationship between leptin concentration and bone metabolism in the human fetus. J Clin Endocrinol Metab 85, 19971999.
  • Schubring C, Kiess W, Englaro P & Rascher W (1997). Levels of leptin in maternal serum, amniotic fluid and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 82, 14801483.
  • Shimon I, Yan X, Magoffin DA, Friedman TC & Melmed S (1998). Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. J Clin Endocrinol Metab 83, 40594064.
  • Smith JT & Waddell BJ (2002). Leptin receptor expression in the rat placenta: changes in Ob-Ra, Ob-Rb, and Ob-Re with gestational age and suppression by glucocorticoids. Biol Reprod 67, 12041210.
  • Smith JT & Waddell BJ (2003). Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology 144, 30243030.
  • Sudgen MC, Langdown ML, Munns MJ & Holness MJ (2001). Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 145, 529539.
  • Thomas L, Wallace JM, Aitken RP, Mercer JG, Trayhurn P & Hoggard N (2001). Circulating leptin during ovine pregnancy in relation to maternal nutrition, body composition and pregnancy outcome. J Endocrinol 169, 465476.
  • Torday JS & Rehan VK (2002). Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. Am J Physiol Lung Cell Mol Physiol 283, L130L135.
  • Torday JS, Sun H, Wang L, Torres E, Sunday ME & Rubin LP (2002). Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol 282, L405L410.
  • Trayhurn P & Bing C (2006). Appetite and energy balance signals from adipocytes. Phil Trans R Soc B Biol Sci 361, 12371249.
  • Udagawa J, Hatta T, Hashimoto R & Otani H (2007). Roles of leptin in prenatal and perinatal brain development. Congenit Anom (Kyoto) 47, 7783.
  • Valuniene M, Verkauskiene R, Boguszewski M, Dahlgren J, Lasiene D, Lasas L & Wikland KA (2007). Leptin levels at birth and in early postnatal life in small- and appropriate-for-gestational-age infants. Medicina (Kaunas) 43, 784791.
  • Varvarigou A, Mantzoros CS & Beratis NG (1999). Cord blood leptin concentrations in relation to intrauterine growth. Clin Endocrinol 50, 177183.
  • Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH & Harris M (2005). Neonatal leptin treatment reverses developmental programming. Endocrinology 146, 42114216.
  • Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH & Harris M (2008). The effect of neonatal leptin treatment on postnatal weight gain in male rats is dependent on maternal nutritional status during pregnancy. Endocrinology 149, 19061913.
  • White V, Gonzalez E, Capobianco E, Pustovrh C, Martinez N, Higa R, Baier M & Jawerbaum A (2006). Leptin modulates nitric oxide production and lipid metabolism in human placenta. Reprod Fertil Dev 18, 425432.
  • White V, Gonzalez E, Capobianco E, Pustovrh C, Sonez C, Romanini MC & Jawerbaum A (2004). Modulatory effect of leptin on nitric oxide production and lipid metabolism in term placental tissues from control and streptozocin-induced diabetic rats. Reprod Fertil Dev 16, 363372.
  • Wyrwoll CS, Mark PJ & Waddell BJ (2005). Directional secretion and transport of leptin and expression of leptin receptor isoforms in human placental BeWo cells. Mol Cell Endocrinol 241, 7379.
  • Yamashita H, Shao J, Ishizuka T, Klepcyk PJ, Muhlenkamp P, Qiao L, Hoggard N & Friedman JE (2001) Leptin administration prevents spontaneous gestational diabetes in heterozygous Leprdb/+ mice: effects on placental leptin and fetal growth. Endocrinology 142, 28882897.
  • Yuen BSJ, McMillen IC, Symonds ME & Owens PC (1999). Abundance of leptin mRNA in fetal adipose tissue is related to fetal bodyweight. J Endocrinol 163, R1R4.
  • Yuen BSJ, Owens PC, McFarlane JR, Symonds ME, Edwards LJ, Kauter KG & McMillen IC (2002). Circulating leptin concentrations are positively related to leptin messenger RNA expression in the adipose tissue of fetal sheep in the pregnant ewe fed at or below maintenance energy requirements during late gestation. Biol Reprod 67, 911916.
  • Yuen BSJ, Owens PC, Muhlhausler BS, Roberts CT, Symonds ME, Keisler DH, McFarlane JR, Kauter KG, Evens Y & McMillen JC (2003). Leptin alters the structural and functional characteristics of adipose tissue before birth. FASEB J 17, 11021104.
  • Yuen BSJ, Owens PC, Symonds ME, Keisler DH, McFarlane JR, Kauter KG & McMillen IC (2004). Effects of leptin on fetal plasma adrenocorticotropic hormone and cortisol concentrations and the timing of parturition in the sheep. Biol Reprod 70, 16501657.

Appendix

  1. Top of page
  2. Abstract
  3. Expression of leptin in fetal and placental tissues
  4. Leptin as a signal in response to the intrauterine environment
  5. Leptin and growth of the fetus
  6. Leptin and energy balance of the fetus
  7. Leptin and maturation of the fetus near term
  8. Conclusions
  9. References
  10. Appendix

Acknowledgements

The authors would like to thank past and present members of the Perinatal Physiology research group in the Department of Physiology, Development and Neuroscience for their contributions and support, and are grateful to the BBSRC, Isaac Newton Trust and Royal Society for funding.